Financhill
Back

RedHill Biopharma Ltd. 10K Form

Sell
30

RDHL
RedHill Biopharma Ltd.

Last Price:
$1.20
Seasonality Move:
-10.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RDHL News And Ratings

See the #1 stock for the next 7 days that we like better than RDHL

RDHL Financial Statistics

Sales & Book Value

Annual Sales: $8.1M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.05
Price / Book: 1.13

Profitability

Net Income (TTM): $0
Gross Margin: $4.9M
Return on Equity: 0%
Return on Assets: 0%

RedHill Biopharma Ltd. Earnings Forecast

Key RedHill Biopharma Ltd. Financial Ratios

  • The Gross Profit Margin over the past 16 years for RDHL is 60.31%.
  • The Selling, General & Administrative Expenses for RDHL have been equal to 192.92% of Gross Profit Margin.
  • The Research & Development expenses have been 19.74% of Revenue.
  • The Net Earning history of RDHL is -102.80% of Total Revenues.
  • Per Share Earnings over the last 16 years have been positive in 8 years.

RedHill Biopharma Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RDHL
CUSIP: 757468
Website: redhillbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.74
Quick Ratio: 0.53

Price-to-Earnings

Trailing P/E Ratio: 0.02
Forward P/E Ratio: 0

RDHL Technical Analysis vs Fundamental Analysis

Sell
30
RedHill Biopharma Ltd. (RDHL) is a Sell

Is RedHill Biopharma Ltd. a Buy or a Sell?